Action of metabolic inhibitors and energy-rich phosphate compounds on cochlear potentials.
D000200:Action Potentials / Q000187:drug effects; D000227:Adenine Nucleotides / Q000008:administration & dosage*; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000008:administration & dosage; D000818:Animals; D000963:Antimetabolites / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage; D001386:Azides / Q000008:administration & dosage; D002462:Cell Membrane / Q000201:enzymology; D003051:Cochlea / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D003486:Cyanides / Q000008:administration & dosage; D004140:Dinitrophenols / Q000008:administration & dosage; D005071:Evoked Potentials / Q000187:drug effects; D006168:Guinea Pigs
D000227:Adenine Nucleotides; D000963:Antimetabolites; D001386:Azides; D003486:Cyanides; D004140:Dinitrophenols; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D001241:Aspirin